These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21409400)

  • 1. Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
    Gardan-Salmon D; Dixon JM; Lonergan SM; Selsby JT
    Eur J Appl Physiol; 2011 Nov; 111(11):2763-73. PubMed ID: 21409400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
    Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
    Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.
    Rayavarapu S; Coley W; Cakir E; Jahnke V; Takeda S; Aoki Y; Grodish-Dressman H; Jaiswal JK; Hoffman EP; Brown KJ; Hathout Y; Nagaraju K
    Mol Cell Proteomics; 2013 May; 12(5):1061-73. PubMed ID: 23297347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
    Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
    J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophin deficiency disrupts muscle clock expression and mitochondrial quality control in
    Hardee JP; Caldow MK; Chan ASM; Plenderleith SK; Trieu J; Koopman R; Lynch GS
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C288-C296. PubMed ID: 34191629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.
    Timpani CA; Trewin AJ; Stojanovska V; Robinson A; Goodman CA; Nurgali K; Betik AC; Stepto N; Hayes A; McConell GK; Rybalka E
    Neurotherapeutics; 2017 Apr; 14(2):429-446. PubMed ID: 27921261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the skeletal muscle proteome in mdx mice at different ages.
    Ge Y; Molloy MP; Chamberlain JS; Andrews PC
    Electrophoresis; 2004 Aug; 25(15):2576-85. PubMed ID: 15300778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.
    Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I
    J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds.
    Gamberi T; Fiaschi T; Valocchia E; Modesti A; Mantuano P; Rolland JF; Sanarica F; De Luca A; Magherini F
    J Proteomics; 2018 Jan; 170():43-58. PubMed ID: 28966053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
    Terrill JR; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers.
    Holland A; Henry M; Meleady P; Winkler CK; Krautwald M; Brinkmeier H; Ohlendieck K
    Molecules; 2015 Jun; 20(6):11317-44. PubMed ID: 26102067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophinopathy-associated dysfunction of Krebs cycle metabolism.
    Lindsay A; Chamberlain CM; Witthuhn BA; Lowe DA; Ervasti JM
    Hum Mol Genet; 2019 Mar; 28(6):942-951. PubMed ID: 30476171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
    Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
    Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.